These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7635560)

  • 1. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE).
    Bliss JM; Ford D; Swerdlow AJ; Armstrong BK; Cristofolini M; Elwood JM; Green A; Holly EA; Mack T; MacKie RM
    Int J Cancer; 1995 Aug; 62(4):367-76. PubMed ID: 7635560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study.
    Elwood JM; Gallagher RP; Hill GB; Spinelli JJ; Pearson JC; Threlfall W
    Br Med J (Clin Res Ed); 1984 Jan; 288(6411):99-102. PubMed ID: 6419839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study.
    Lock-Andersen J; Drzewiecki KT; Wulf HC
    Acta Derm Venereol; 1999 Jan; 79(1):74-80. PubMed ID: 10086866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling.
    Olsen CM; Carroll HJ; Whiteman DC
    Int J Cancer; 2010 Nov; 127(10):2430-45. PubMed ID: 20143394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous factors related to the risk of malignant melanoma.
    Beral V; Evans S; Shaw H; Milton G
    Br J Dermatol; 1983 Aug; 109(2):165-72. PubMed ID: 6871096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure.
    Beitner H; Norell SE; Ringborg U; Wennersten G; Mattson B
    Br J Dermatol; 1990 Jan; 122(1):43-51. PubMed ID: 2297503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn.
    Elwood JM; Whitehead SM; Davison J; Stewart M; Galt M
    Int J Epidemiol; 1990 Dec; 19(4):801-10. PubMed ID: 2084006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of host factors to identify people at high risk for cutaneous malignant melanoma .
    Marrett LD; King WD; Walter SD; From L
    CMAJ; 1992 Aug; 147(4):445-53. PubMed ID: 1498755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors.
    Holly EA; Aston DA; Cress RD; Ahn DK; Kristiansen JJ
    Am J Epidemiol; 1995 May; 141(10):934-42. PubMed ID: 7741123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fair complexion and risk of malignant melanoma of the skin based on experience from the Danish Cancer Registry.
    Osterlind A
    Recent Results Cancer Res; 1993; 128():91-100. PubMed ID: 8356336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin.
    Khalesi M; Whiteman DC; Tran B; Kimlin MG; Olsen CM; Neale RE
    Cancer Epidemiol; 2013 Oct; 37(5):534-43. PubMed ID: 23849507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigmentary characteristics and moles in relation to melanoma risk.
    Titus-Ernstoff L; Perry AE; Spencer SK; Gibson JJ; Cole BF; Ernstoff MS
    Int J Cancer; 2005 Aug; 116(1):144-9. PubMed ID: 15761869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women.
    Veierød MB; Weiderpass E; Thörn M; Hansson J; Lund E; Armstrong B; Adami HO
    J Natl Cancer Inst; 2003 Oct; 95(20):1530-8. PubMed ID: 14559875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination.
    Nijsten T; Leys C; Verbruggen K; Verlinden V; Drieghe J; Stas M; Lambert J; DeGreef H; Garmyn M
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):332-9. PubMed ID: 15857460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case-control study.
    Schmidt-Pokrzywniak A; Jöckel KH; Bornfeld N; Sauerwein W; Stang A
    Ophthalmology; 2009 Feb; 116(2):340-8. PubMed ID: 19091418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors.
    Osterlind A; Tucker MA; Hou-Jensen K; Stone BJ; Engholm G; Jensen OM
    Int J Cancer; 1988 Aug; 42(2):200-6. PubMed ID: 3403065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE).
    Ford D; Bliss JM; Swerdlow AJ; Armstrong BK; Franceschi S; Green A; Holly EA; Mack T; MacKie RM; Osterlind A
    Int J Cancer; 1995 Aug; 62(4):377-81. PubMed ID: 7635561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Laino AM; Berry EG; Jagirdar K; Lee KJ; Duffy DL; Soyer HP; Sturm RA
    Br J Dermatol; 2018 May; 178(5):1119-1127. PubMed ID: 29315480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to ultraviolet B is a risk factor for cutaneous melanoma in a Mediterranean population: results from an Italian case-control study.
    Chiarugi A; Ceroti M; Palli D; Cevenini G; Guarrera M; Carli P
    Clin Exp Dermatol; 2009 Jan; 34(1):8-15. PubMed ID: 19076789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.